Nemes Rush Group
ONC icon

Nemes Rush Group’s BeOne Medicines Ltd ONC Stock Holding History

Nemes Rush Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.46K Hold
4
– – ﹤0.01% 800
2026
Q2 		$1.14K Hold
4
– – ﹤0.01% 850
2026
Q1 		$1.19K Hold
4
– – ﹤0.01% 805
2025
Q4 		$1.22K Buy
+4
New +$1.31K ﹤0.01% 791

Other funds holding ONC

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Barings
Barings Charlotte, North Carolina $5.84B AUM 11.61% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Nemes Rush Group's ONC Position: Q3 2026 in Review

Nemes Rush Group held its BeOne Medicines Ltd (ONC) position steady in Q3 2026 at 4 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Nemes Rush Group first reported a position in ONC in Q4 2025 and has held it in 4 quarters since. 135 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Nemes Rush Group held 4 shares of BeOne Medicines Ltd worth $1.46K as of Q3 2026.
  • Nemes Rush Group left its BeOne Medicines Ltd share count unchanged in Q3 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #800 holding.
  • Nemes Rush Group first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 4 quarters since.
  • 135 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.